Skip to search.
 TSX Down 2.15% TSX Ventures Down 1.81%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.21 Down 0.01(3.23%) Jun 29, 4:00PM EDT
|Pre-Market : 0.20 Down 0.00 (2.39%) 8:14AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:0.22
Open:0.22
Bid:0.20 x 300
Ask:0.22 x 1500
1y Target Est:1.45
Beta:-0.52
Next Earnings Date:N/A
Day's Range:0.20 - 0.22
52wk Range:0.20 - 0.40
Volume:993,102
Avg Vol (3m):1,583,910
Market Cap:50.94M
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
HEBDown 3.23%50.94M
GILDDown 3.38%169.67B
MRKDown 2.05%161.86B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):321.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the Un... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback